Monitor for any future 13D conversion or increased activism from other holders; Bank of America's passive stake is routine for a large financial institution and does not signal a control agenda.
Price Chart
Executive Summary
Bank of America Corporation filed a new Schedule 13G disclosing a passive 6.4% stake in Jasper Therapeutics, Inc., representing 2,133,861 shares of voting common stock as of September 30, 2026. This is a new filing by Bank of America, not an amendment, and certifies no intent to influence control.
Key Financial Metrics
Key Facts
- Bank of America Corp filed a new Schedule 13G (not an amendment) on October 28, 2026.
- Beneficial ownership: 2,133,861 shares of voting common stock.
- Stake represents 6.4% of outstanding shares, based on 33,274,561 shares outstanding per the issuer's DEFA14A filed October 19, 2026.
- The filing certifies passive intent under Rule 13d-1(b) and states securities were acquired in the ordinary course of business.
- Previous 13G filings for Jasper Therapeutics were by Millennium Management (July 2026), Morgan Stanley (May 2026), and Soleus Capital Master Fund (May 2026).
Financial Impact
Stake valued at approximately $1.09 million based on market cap of $17M and 6.4% ownership.
Risk Factors
- No activist intent indicated; passive stake limits influence on management.
- Small market cap ($17M) makes the stock vulnerable to volatility from other filings or news.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000070858-26-000538 |
| Document: 0000070858-26-000538-index.html | 0000070858-26-000538 |
| Document: 0000070858-26-000538.txt | 0000070858-26-000538 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 1d ago | SC 13G | $0.5388 | awaiting T+5 | awaiting T+5 | $0.5320 (−1.26%) |
Oct 23, 2026 6d ago | SC TO-I/A | $0.5054 | awaiting T+5 | awaiting T+5 | $0.5320 (+5.26%) |
Oct 20, 2026 9d ago | DEF 14A | $0.4999 $0.5189 | ▲ +3.80% | ▲ +3.72% | $0.5320 (+6.42%) |
Oct 15, 2026 14d ago | 8-K | $0.5321 $0.4956 | ▼ −6.86% | ▼ −5.85% | $0.5320 (−0.02%) |
Oct 15, 2026 14d ago | Press Release | $0.5320 $0.4960 | ▲ +6.77% | ▲ +5.75% | $0.5320 (−0.00%) |
Oct 14, 2026 15d ago | S-3 | $0.5321 $0.4956 | ▲ +6.86% | ▲ +5.85% | $0.5320 (+0.02%) |
Oct 7, 2026 22d ago | 8-K | $0.5697 $0.5010 | ▼ −12.06% | ▼ −11.08% | $0.5320 (−6.62%) |
Oct 7, 2026 22d ago | SC TO-I | $0.5697 $0.5010 | ▼ −12.06% | ▼ −11.08% | $0.5320 (−6.62%) |
Sep 24, 2026 5w ago | 25-NSE | $0.6091 $0.5652 | ▲ +7.21% | ▲ +6.99% | $0.5320 (+12.66%) |
Aug 14, 2026 10w ago | Press Release | $0.7901 $0.7160 | ▼ −9.38% | ▼ −8.01% | $0.5320 (−32.67%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers